Moreover, captured tumor antigens are released through oncolysis and migrate to regional lymphoid structures to activate tumor-specific T cells to destroy cancer cells by production of perforin and granzyme B, and their recognition by T cells through expression of MHC molecules and presentation of tumor antigens on the surface of cancer cells (Del Prete et al., 2023). The gene discussed is PRF1; the disease is neoplasm.